Will Oklo Stock Double?
Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…
Sell
32
ACXP Quote, Financials, Valuation and Earnings
Last price:
$0.44
Seasonality move
:
-14.36%
Day range:
$0.44 - $0.49
52-week range:
$0.30 - $3.33
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.63x
Volume:
534.1K
Avg. volume:
12.6M
1-year change:
-80.26%
Market cap:
$10.7M
Revenue:
--
EPS (TTM):
-$0.70
Earnings Data
Next earnings date for ACXP
Aug 08
2025
Most recent earnings per share
-$0.11
Beat by $0.03
(May 13/2025)
Consensus Estimate
-$0.14
(May 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ACXP Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.12 | -- |
| 08/08/2025 | Q2 | -- | -- | -- | -$0.11 | -- |
| 05/13/2025 | Q1 | -- | -- | -$0.11 | -$0.14 | $0.03 |
| 03/18/2025 | Q4 | -- | -- | -$0.16 | -$0.18 | $0.02 |
| 11/13/2024 | Q3 | -- | -- | -$0.17 | -$0.23 | $0.06 |
| 08/09/2024 | Q2 | -- | -- | -$0.26 | -$0.28 | $0.02 |
| 05/15/2024 | Q1 | -- | -- | -$0.28 | -$0.24 | -$0.04 |
| 03/18/2024 | Q4 | -- | -- | -$0.38 | -$0.26 | -$0.12 |
| 11/14/2023 | Q3 | -- | -- | -$0.24 | -$0.25 | $0.01 |
| 08/14/2023 | Q2 | -- | -- | -$0.28 | -$0.23 | -$0.05 |
| 05/12/2023 | Q1 | -- | -- | -$0.25 | -$0.25 | -- |
| 03/16/2023 | Q4 | -- | -- | -$0.28 | -$0.31 | $0.03 |
| 11/14/2022 | Q3 | -- | -- | -$0.32 | -- | -- |
| 08/16/2022 | Q2 | -- | -- | -$0.26 | -- | -- |
| 05/11/2022 | Q1 | -- | -- | -$0.26 | -- | -- |
| 03/17/2022 | Q4 | -- | -- | -$0.22 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$0.46 | -- | -- |
| 08/17/2021 | Q2 | -- | -- | -$0.57 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.15 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.11 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.14 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.10 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.13 | -- | -- |
Acurx Pharmaceuticals Earnings Questions
-
How Much did Acurx Pharmaceuticals Generate in Revenue Last Quarter?
Acurx Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did Acurx Pharmaceuticals Beat Earnings Last Quarter?
Acurx Pharmaceuticals announced earnings per share of -$0.11 which represents a beat of analyst forecast a -$0.14 per share.
-
Is Acurx Pharmaceuticals Profitable?
Acurx Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Acurx Pharmaceuticals EPS Next Year?
Acurx Pharmaceuticals's earnings are forecast to decrease from -$0.87 per share to -$0.89 per share next year representing a decrease of -48.28%.
-
When is Acurx Pharmaceuticals's Earnings Date?
Acurx Pharmaceuticals's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why a $5 Stock Is Suddenly a Cash Machine
If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…
Is Roku Stock Undervalued Now?
At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…
Stock Ideas
Buy
69
Is NVDA Stock a Buy?
Market Cap: $4T
P/E Ratio: 56x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 43x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
77
VBTX alert for Jul 15
Veritex Holdings [VBTX] is down 0.88% over the past day.
Buy
72
MNPR alert for Jul 15
Monopar Therapeutics [MNPR] is down 2.13% over the past day.
Buy
56
NBIS alert for Jul 15
Nebius Group NV [NBIS] is up 4.68% over the past day.
